Literature DB >> 17978587

What should our blood pressure goal be in patients with diabetes?

William C Cushman.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17978587      PMCID： PMC8109909          DOI： 10.1111/j.1524-6175.2007.07224.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  14 in total

1.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

2.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J Tuomilehto; D Rastenyte; W H Birkenhäger; L Thijs; R Antikainen; C J Bulpitt; A E Fletcher; F Forette; A Goldhaber; P Palatini; C Sarti; R Fagard
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

3.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

4.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

5.  Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Paul K Whelton; Joshua Barzilay; William C Cushman; Barry R Davis; Ekambaram Iiamathi; John B Kostis; Frans H H Leenen; Gail T Louis; Karen L Margolis; David E Mathis; Jamal Moloo; Chuke Nwachuku; Deborah Panebianco; David C Parish; Sara Pressel; Debra L Simmons; Udho Thadani
Journal:  Arch Intern Med       Date:  2005-06-27

6.  Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Authors:  R O Estacio; B W Jeffers; N Gifford; R W Schrier
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

7.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

8.  Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  William C Cushman; Richard H Grimm; Jeffrey A Cutler; Gregory W Evans; Sarah Capes; Marshall A Corson; Laurie S Sadler; Michael H Alderman; Kevin Peterson; Alain Bertoni; Jan N Basile
Journal:  Am J Cardiol       Date:  2007-04-16       Impact factor: 2.778

9.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

10.  Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?

Authors:  Alberto Zanchetti; Lennart Hansson; Denis Clement; Dag Elmfeldt; Stevo Julius; Telma Rosenthal; Bernard Waeber; Hans Wedel
Journal:  J Hypertens       Date:  2003-04       Impact factor: 4.844
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.